Company intelligence / Profile preview

Switch Bioworks

San Carlos, California, United Statesswitchbioworks.com ↗

Ownership: Private
Employees: ~15
Development stage: Preclinical

Overview

Switch Bioworks has developed a proprietary platform that engineers naturally occurring, symbiotic soil microbes with genetic circuits to enable controlled nitrogen fertilizer production directly at plant roots. Their lead product is a powder containing these engineered microbes, which are applied at planting. The company’s approach aims to reduce reliance on fossil fuel-based fertilizers and lower greenhouse gas emissions. As of mid-2025, the technology is in advanced development with greenhouse and field trials underway in the U.S. and internationally; no clinical/marketed results yet.

Modalities: Microbial therapySynthetic biology platform (engineered microbes as living fertilizer)
Industry: Agriculture & AgTech

Partnerships

Bill & Melinda Gates Foundation grant support

Beyond the preview

Go deeper on Switch Bioworks.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Switch Bioworks.

Explore the full profile